GS

Ghanshyam Shankarrao Dehari

Active Director Director DIN 10629698
DIN 10629698 First appointment May 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Ghanshyam Shankarrao Dehari

Data last updated:

Ghanshyam Shankarrao Dehari is a Director at Cordium Pharmaceuticals Private Limited (since 2024). The company operates in Pharma.

DIN 10629698
Primary Designation Director
Industry Pharma
First Appointment 15 May 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director15 May 20242024Active

Board colleagues of Ghanshyam Shankarrao Dehari

NameDINCompanyDesignation
Rakhi Dehari10629699Cordium Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Cordium Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ghanshyam Shankarrao Dehari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ghanshyam Shankarrao Dehari

Ghanshyam Shankarrao Dehari currently holds 1 directorship: Cordium Pharmaceuticals Private Limited (Director, since 15 May 2024).

Ghanshyam Shankarrao Dehari was first appointed on 15 May 2024 as Director at Cordium Pharmaceuticals Private Limited.

The current boards of Ghanshyam Shankarrao Dehari's companies include Rakhi Dehari (Cordium Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available